Rising Biosciences Stock Price, News & Analysis
Company Description
Rising Biosciences (OTC Link: RBII) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $80.2K.
RBII stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of RBII stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Rising Biosciences (RBII) stock last traded at $0.0000. At a market capitalization of $80.2K, RBII is classified as a micro-cap stock with approximately 1.1B shares outstanding.
Latest News
Rising Biosciences has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include acquisition. View all RBII news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RBII Company Profile & Sector Positioning
Rising Biosciences (RBII) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing RBII often look at related companies in the same sector, including Evergreen Sustainable Enterprises Inc (EGSE), Western Sierra R (WSRC), Viaderma (VDRM), Cryomass Technologies Inc (CRYM), and Hero Technologies Inc (HENC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RBII's relative position within its industry.